Kurt Ritter
Inventor
Stats
- 42 US patents issued
- 59 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 42 US Patents Issued
- 59 US Applications Filed
- 884 Total Citation Count
- Aug 8, 2023 Most Recent Filing
- Jan 5, 1994 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| SANOFI-AVENTIS DEUTSCHLAND GMBH | 2
7 1 1 | 2002
2004 2007 2008 |
| ABBVIE DEUTSCHLAND GMBH & CO KG | 1
2 1 2 2 2 2 2 2 2 | 1995
1996 1997 1998 2000 2001 2002 2005 2008 2010 |
| ABBOTT LABORATORIES | 2
| 2001
|
| AVENTIS PHARMA S.A. | 2
4 5 | 2004
2007 2008 |
| ABBOTT GMBH & CO. KG | 1
2 | 2001
2002 |
| BASF AKTIENGESELLSCHAFT | 1
1 2 1 1 | 1994
1995 1997 1998 2001 |
| ABBVIE INC. | 2
| 2002
|
| SANOFI | 4
3 18 2 4 | 2007
2011 2012 2015 2016 |
Inventor Addresses
| Address | Duration |
|---|---|
| Frankfurt Am Main, DE | Dec 09, 04 - Feb 02, 17 |
| Frankfurt am Main, DE | Oct 23, 03 - Apr 04, 24 |
| Frankfurt, Brandenburg, DE | Sep 18, 03 - Jan 08, 04 |
| Frankfurt, DE | Jan 09, 03 - May 13, 14 |
| Heidelberg, Baden-Wurttemberg, DE | Jan 12, 06 - Jan 12, 06 |
| Heidelberg, DE | Mar 26, 96 - May 14, 13 |
| Newton, DE | Oct 24, 02 - Oct 24, 02 |
| Newton, MA | Sep 15, 98 - Jul 04, 06 |
| Scottsdale, AZ | Feb 15, 07 - Feb 15, 07 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 1 |
| A61C: | DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE | 1 |
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 45 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2024/0109,882 | 2024 | ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF | 0 |
| 11897876 | 2024 | Isoxazolidines as RIPK1 inhibitors and use thereof | 0 |
| 2023/0219,937 | 2023 | ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF | 0 |
| 2023/0203,027 | 2023 | ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF | 0 |
| 10392366 | 2019 | Azetidine compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders | 1 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.